Skip to main content

Ingrid E. Christensen

PhD stipendiat
https://orcid.org/0000-0002-8429-8152
Se Google Scholar profil
Se publikasjoner i PubMed

Utdanning

  • Lege (MD) ved det medisinske fakultet, Universitet i Oslo

Stilling

  • PhD-stipendiat, Klinikk for revmatologi, poliklinikk og forskning, Diakonhjemmet sykehus

Interessefelt

  • Revmatiske leddsykdommer
  • Vaksiner Infeksjoner ved behandling av revmatisk leddsykdom
  • Epidemiologi
  • Randomiserte kontrollerte studier

E-post

Denne e-postadressen er beskyttet mot programmer som samler e-postadresser. Du må aktivere javaskript for å kunne se den.

Telefon

Besøksadresse

Diakonhjemmet sykehus
Forstanderboligen
Reidar Kobros vei 8
0370 Oslo

Postadresse

Diakohjemmet sykehus
Postboks 23 Vinderen
0319 Oslo

Prosjekter

WP6 - Langtidsoppfølging

NOR-DMARD

Det norske registeret for antirevmatiske legemidler

Prosjektleder:
Tore K. Kvien
WP2 - Presisjonsmedisin

Nor-vaC

Immunologisk respons på COVID-19 vaksine hos pasienter på immunosuppressiv behandling

Prosjektleder:
Guro Løvik Goll

Publikasjoner

Publikasjoner hentet fra Nasjonalt vitenarkiv (NVA):

Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study

Hilde Sofie Sager Ørbo, Kristin Reine Hammersbøen, Joseph Sexton, Ingrid Jyssum, Anne Therese Tveter, Ingrid Egeland Christensen


RMD Open

2024

T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study

Asia-Sophia Fumika Michaela Wolf, Kristin Reine Hammersbøen, Hilde Sofie Sager Ørbo, Sabin Bhandari, Guri Solum, Ingrid Fadum Kjønstad


EBioMedicine

2024

Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study

Hilde Sofie Sager Ørbo, Taissa de Matos Kasahara, Asia-Sophia Fumika Michaela Wolf, Kristin H. Bjørlykke, Joseph Sexton, Ingrid Jyssum


The Lancet Regional Health - Europe

2024

Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study

Kristin H. Bjørlykke, Hilde Sofie Sager Ørbo, Anne Therese Tveter, Ingrid Jyssum, Joseph Sexton, Trung Tran


The Lancet Rheumatology

2022

Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy

Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, Joseph Sexton, Ingrid Egeland Christensen, Trung Tran


RMD Open

2022

The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls—a prospective cohort study

Ingrid Egeland Christensen, Ingrid Jyssum, Anne Therese Tveter, Joseph Sexton, Trung Tran, Siri Mjaaland


BMC Medicine

2022

Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study

Ingrid Egeland Christensen, Siri Lillegraven, Mielnik Pawel, Gunnstein Bakland, Liz Paucar Loli, Joseph Sexton


Annals of the Rheumatic Diseases

2021